These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3024587)

  • 1. Reduction of lipoxygenase products in psoriatic skin homogenates by QA 208-199.
    Schnyder J; Hunziker T; Strasser M; Richardson B; Krebs A
    Arch Dermatol Res; 1986; 278(6):494-6. PubMed ID: 3024587
    [No Abstract]   [Full Text] [Related]  

  • 2. Modulation of eicosanoid formation by lesional skin of psoriasis: an ex vivo skin model.
    Fogh K; Iversen L; Herlin T; Kragballe K
    Acta Derm Venereol; 1993 Jun; 73(3):191-3. PubMed ID: 8105616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic and clinical effects of lonapalene (RS 43179), a 5-lipoxygenase inhibitor, in psoriasis.
    Black AK; Camp RD; Mallet AI; Cunningham FM; Hofbauer M; Greaves MW
    J Invest Dermatol; 1990 Jul; 95(1):50-4. PubMed ID: 2164070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arachidonic acid in psoriasis. Pathogenic role and pharmacological regulation.
    Kragballe K; Voorhees JJ
    Acta Derm Venereol Suppl (Stockh); 1985; 120():12-7. PubMed ID: 3010612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneous distribution of lipoxygenase products in psoriatic skin lesions.
    Fogh K; Kiil J; Herlin T; Ternowitz T; Kragballe K
    Arch Dermatol Res; 1987; 279(8):504-11. PubMed ID: 2829753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dithranol treatment on arachidonic acid and its lipoxygenase products in psoriasis.
    Barr RM; Wong E; Cunningham FM; Mallet AI; Greaves MW
    Arch Dermatol Res; 1989; 280(8):474-6. PubMed ID: 2537608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro inhibition of leukotriene B4 formation by exogeneous 5-lipoxygenase inhibitors is associated with enhanced generation of 15-hydroxy-eicosatetraenoic acid (15-HETE) by human neutrophils.
    Fogh K; Herlin T; Kragballe K
    Arch Dermatol Res; 1988; 280(7):430-6. PubMed ID: 2849922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukotrienes and other lipoxygenase products in the pathogenesis and therapy of psoriasis and other dermatoses.
    Voorhees JJ
    Arch Dermatol; 1983 Jul; 119(7):541-7. PubMed ID: 6305285
    [No Abstract]   [Full Text] [Related]  

  • 9. Biosynthesis of lipoxygenase products by enzyme preparations from normal and psoriatic skin.
    Ziboh VA; Casebolt TL; Marcelo CL; Voorhees JJ
    J Invest Dermatol; 1984 Dec; 83(6):426-30. PubMed ID: 6094672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical steroid treatment reduces arachidonic acid and leukotriene B4 in lesional skin of psoriasis.
    Wong E; Barr RM; Cunningham FM; Mistry K; Woollard PM; Mallet AI; Greaves MW
    Br J Clin Pharmacol; 1986 Dec; 22(6):627-32. PubMed ID: 3032226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous responses to lipoxygenase products of arachidonic acid.
    Dowd PM; Greaves MW
    Acta Derm Venereol Suppl (Stockh); 1985; 120():18-22. PubMed ID: 3010613
    [No Abstract]   [Full Text] [Related]  

  • 12. Eicosanoids in acute and chronic psoriatic lesions: leukotriene B4, but not 12-hydroxy-eicosatetraenoic acid, is present in biologically active amounts in acute guttate lesions.
    Fogh K; Herlin T; Kragballe K
    J Invest Dermatol; 1989 Jun; 92(6):837-41. PubMed ID: 2542417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective decrease of 15-hydroxyeicosatetraenoic acid (15-HETE) formation in uninvolved psoriatic dermis.
    Kragballe K; Duell EA; Voorhees JJ
    Arch Dermatol; 1986 Aug; 122(8):877-80. PubMed ID: 3090943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of chemotactic lipoxygenase products of arachidonate metabolism in psoriatic skin.
    Grabbe J; Czarnetzki BM; Rosenbach T; Mardin M
    J Invest Dermatol; 1984 May; 82(5):477-9. PubMed ID: 6096449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of leukotriene B4 (LTB4) and 12-hydroxy-5,8,10,14-eicosatetraenoic acid (12-HETE) in human keratinocytes.
    Wheelan P; Travers JB; Morelli JG; Murphy RC
    Ann N Y Acad Sci; 1994 Nov; 744():39-49. PubMed ID: 7825861
    [No Abstract]   [Full Text] [Related]  

  • 16. An enzymatic method for distinguishing the stereoisomers of 12-hydroxyeicosatetraenoic acid in human epidermis and psoriatic scale.
    Opas EE; Argenbright LW; Humes JL
    Br J Dermatol; 1989 Jan; 120(1):49-58. PubMed ID: 2517876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of leukotriene B4 synthesis in human polymorphonuclear leukocytes after exposure to meningococcal lipopolysaccharide.
    Salari SH; DeVoe IW; Powell WS
    Biochem Biophys Res Commun; 1982 Feb; 104(4):1517-24. PubMed ID: 6280717
    [No Abstract]   [Full Text] [Related]  

  • 18. The chemokinetic response of psoriatic and normal polymorphonuclear leukocytes to arachidonic acid lipoxygenase products.
    Cunningham FM; Wong E; Woollard PM; Greaves MW
    Arch Dermatol Res; 1986; 278(4):270-3. PubMed ID: 3017241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of chemo-attractant lipoxygenase products in the pathogenesis of psoriasis.
    Camp RD; Mallet AI; Cunningham FM; Wong E; Woollard PM; Dowd P; Kobza Black A; Greaves MW
    Br J Dermatol; 1985 Jul; 113 Suppl 28():98-103. PubMed ID: 2990521
    [No Abstract]   [Full Text] [Related]  

  • 20. High-performance liquid chromatographic quantitation of cyclooxygenase and lipoxygenase metabolites of arachidonic acid from rat polymorphonuclear leukocytes.
    Tordjman C; Serkiz B; Rambaud F; Bonnet J; Volland JP
    J Chromatogr; 1990 Oct; 532(1):135-43. PubMed ID: 1964162
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.